Lipoxins and other arachidonate derived mediators in bronchial asthma

Thorax

Volumn 55, Issue SUPPL. 2, 2000, Pages

  Chavis, C ^a   Vachier, I ^a   Godard, P ^a   Bousquet, J ^a   Chanez, P ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIMYCIN; CORTICOSTEROID; LIPOXIN; THEOPHYLLINE;

ASTHMA; CELL STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; MEDIATOR RELEASE; MONOCYTE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL;

ARACHIDONIC ACID; ASTHMA; CALCIMYCIN; CELL CULTURE TECHNIQUES; EICOSANOIDS; GLUCOCORTICOIDS; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; IONOPHORES; MACROPHAGES, ALVEOLAR; MONOCYTES; NEUTROPHILS;

EID: 0033806436     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. 1 Christie PE, Spur BW, Lee TH. The effects of lipoxin A4 on airway responses in asthmatic subjects. Am Rev Respir Dis 1992;145:1281-4.
2. 2 Serhan CN. Lipoxins: biosynthesis and evidence for their involvement in respiratory disease. In: Robinson C, ed. Lipid mediators in allergic diseases of the respiratory tract. Boca Raton: CRC Press, 1994: 65-78.
3. 3 Drazen JM. Effects of leukotrienes on airway function. In: Crystal RG, West JB, Barnes PJ, Weibel ER, eds. The lung. 2nd edn. Philadelphia, New York: Lippincott-Raven, 1997: 1287-96.
4. 4 Lam S, Chan H, LeRiche JC, et al. Release of leukotrienes in patients with bronchial asthma. J Allergy Clin Immunol 1988;81:711-7.
5. 5 Wenzel SE, Larsen GL, Johnston K, et al. Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis 1990;142:112-9.
6. 6 Lee TH, Arm J. Leukotrienes. Allergy Proc 1991;12:139-42.
7. 7 Borgeat P. Biochemistry of the lipoxygenase pathways in neutrophils. Can J Physiol Pharmacol 1989;67:936-42.
8. 8 Serhan CN, Hamberg M, Samuelsson B. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci USA 1984;83:1983-7.
9. 9 Serhan CN, Hamberg M, Samuelsson B. Trihydroytetraenes: a novel series of compounds formed from arachidonic acid in human leukocytes. Biochem Biophys Res Commun 1984;118:943-9.
10. 10 Kim SJ. Formation of lipoxins by alveolar macrophages. Biochem Biophys Res Commun 1988;150:870-6.
11. 11 Edenius C, Kumlin M, Bjork T, et al. Lipoxin formation in human nasal polyps and bronchial tissue. FEBS Lett 1990;272:25-8.
12. 12 Stenke L, Mansour M, Edenius C, et al. Formation and proliferative effects of lipoxins in human bone marrow. Biochem Biophys Res Comm 1991;180:255-61.
13. 13 Fiore S, Serhan CN. Formation of lipoxins and leukotrienes during recptor-mediated interactions of human platelets and recombinant granulocyte/macrophage colony-stimulating factor-primed neutrophils. J Exp Med 1990;172:1451-7.
14. 14 Serhan CN. On the relationship between leukotriene and lipoxin production by human neutrophils: evidence for differential metabolism of 15(S)-HETE and 5-HETE. Biochim Biophys Acta 1989;1004:158-68.
15. 15 Chavis C, Godard P, Michel FB, et al. Sulfidopeptide leukotrienes contribute to human alveolar macrophage activation in asthma. Prostaglandins Leukot Essential Fatty Acids 1991;42:95-100.
16. 16 Kumlin M, Hamberg M, Granstrom E, et al. 15(S)-hydroxyeicosatetraenoic acid is the major arachidonic acid metabolite in human bronchi: association with airway epithelium. Arch Biochem Biophys 1990;282:254-62.
17. 17 Ang C, Clark E, Young I, et al. 15 hydroxyeicosatetraenoic acid synthesis from exogenous arachidonate by bronchial mucosa. J Lipid Mediators 1990;2:263-9.
18. 18 Lopez S, Vila L, Breviario F, et al. Interleukin-1 increases 15-hydroxyeicosatetraenoic acid formation in cultured human endothelial cells. Biochim Biophys Acta 1993;1170:17-24.
19. 19 Hunter JA, Finkbeiner WE, Nadel JA, et al. Predominant generation of 15-lipoxygenase metabolites of arachidonic acid by epithelial cells from human trachea. Proc Natl Acad Sci USA 1985;82:4633-7.
20. 20 Lee TH, Crea AE, Gant V, et al. Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases. Am Rev Respir Dis 1990;141:1453-8.
21. 4 by stimulated human whole blood. Biol Mass Spectrometry 1991;20:45-52.
22. 22 Lee TH. Lipoxin A4: a novel anti-inflammatory molecule? Thorax 1995;50:1112.
23. 23 Serhan CN, Takano T, Gronert K, et al. Lipoxin and aspirin-triggered 15-epi-lipoxin cellular interactions anti-inflammatory lipid mediators. Clin Chem Lab Med 1999;37:299-309.
24. 24 Diamond P, McGinty A, Sugrue D, et al. Regulation of leukocyte trafficking by lipoxins. Clin Chem Lab Med 1999;37:293-7.
25. 25 Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987;136:225-44.
26. 26 Godard P, Clot J, Jonquet O, et al. Lymphocytes subpopulations in broncho-alveolar lavages of patients with sarcoidosis and hypersensitivity pneumonitis. Chest 1981;80:447-52.
27. 27 Chavis C, Vachier I, Chanez P, et al. 5(S), 15(S)-Dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors. J Exp Med 1996;183:1633-43.
28. 28 Chavis C, Vachier I, Bousquet J, et al. Generation of eicosanoids from 15(S)-hydroxyeicosatetraenoic acid in blood monocytes from steroid-dependent asthmatic patients. Biochem Pharmacol 1998;56:535-41.
29. 29 Chavis C, Godard P, Crastes-de-Paulet A, et al. Formation of lipoxins and leukotrienes by human alveolar macrophages incubated with 15(S)-HETE: a model for cellular cooperation between macrophages and airway epithelial cells. Eicosanoids 1992;5:203-11.
30. 30 Levy BD, Romano M, Chapman HA, et al. Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins. J Clin Invest 1993;92:1572-9.
31. 31 Thomas E, Leroux JL, Blotman F, et al. Conversion of endogenous arachidonic acid to 5(S), 15(S)-diHETE and lipoxins by polymorphonuclear cells from patients with rheumatoid arthritis. Inflammation Res 1995;44:121-4.
32. 32 Stahl GL, Morse DS, Martin SL. Eicosanoid production from porcine neutrophils and platelets: differential production with various agonists. Am J Physiol 1997;272:C1821-8.
33. 4 as a mediator of early and late reactions to antigens in humans: the effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol 1989;83:634-42.
34. 34 Linden M. The effects of beta-2 adrenoreceptor agonists and a corticosteroid, budesonide, on the secretion of inflammatory mediators from monocytes. Br J Pharmacol 1992;107:156-60.
35. 35 De Caterina R, Sicari R, Giannessi D, et al. Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids. J Appl Physiol 1993;75:2368-75.
36. 36 Riddick CA, Ring WL, Baker JR, et al. Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells. Eur J Biochem 1997;246:112-8.
37. 37 Uz T, Dwivedi Y, Savani PD, et al. Glucocorticoids stimulate inflammatory 5-lipoxygenase gene expression and protein translocation in the brain. J Neurochem 1999;73:693-9.